Clinical trial
Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Prospective, Randomized Controlled, Intra-Individual Trial
NCT06461442 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Prospective, Randomized Controlled, Intra-Individual Trial
- Lead sponsor
- University of California, Davis
- Phase
- Phase 4
- Overall status
- Enrolling by invitation
- Start date
- July 1, 2024
- Completion date
- September 1, 2026
- Enrollment
- 73 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratoses